XML 85 R66.htm IDEA: XBRL DOCUMENT v3.6.0.2
Long-Term Incentive Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2000
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum term of awards 10 years      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Number of shares outstanding at beginning of period 23,165,769      
Number of shares granted 4,201,978 4,495,487 3,913,368  
Number of shares forfeited (468,798)      
Number of shares expired (20,645)      
Number of shares exercised (1,742,277)      
Number of shares outstanding at end of period 25,136,027 23,165,769    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted average exercise price - outstanding at beginning of period $ 236.75      
Weighted average exercise price - granted 386.44 $ 537.29 $ 385.33  
Weighted average exercise price - forfeited 398.57      
Weighted average exercise price - expired 420.04      
Weighted average exercise price - exercised 76.79      
Weighted average exercise price - outstanding at end of period $ 269.69 $ 236.75    
Weighted average remaining contractual term (in years) - outstanding 6 years 7 months 28 days    
Instrinsic value - outstanding $ 3,399,815    
Number of shares vested and expected to vest 24,598,430      
Weighted average execise price - vested and expected to vest $ 266.16      
Weighted average remaining contractual term - vested and expected to vest 6 years 7 months 6 days      
Intrinsic value - vested and expected to vest $ 3,397,437      
Number of shares exercisable 15,140,287      
Weighted average exercise price - exercisable $ 166.96      
Weighted average remaining contractual term - exercisable 5 years 2 months 9 days      
Intrinsic value - exercisable $ 3,299,296      
Total intrinsic value - of stock options exercised $ 550,400 $ 1,031,600 $ 1,081,200  
Exercise Price Equal to Market Price [Abstract]        
Number of Options Granted (shares) 4,201,978 4,495,487 3,913,368  
Weighted Average Exercise Price (dollars per share) $ 386.44 $ 537.29 $ 385.33  
Weighted Average Fair Value $ 126.68 $ 181.65 $ 140.38  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Expected volatility 34.00% 35.00% 39.00%  
Expected lives from grant date 5 years 1 month 1 day 5 years 1 month 1 day 5 years 2 months 11 days  
Expected dividend yield 0.00% 0.00% 0.00%  
Risk-free interest rate 1.84% 1.68% 1.62%  
Stock options | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 3 years      
Stock options | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 4 years      
Phantom stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Period within vesting date that awards may be received 30 days      
Non-performance based stock options        
Exercise Price Equal to Market Price [Abstract]        
Non-cash stock-based compensation expense $ 546,000 $ 443,700 $ 306,100  
Unrecognized stock-based compensation cost, net of estimated forfeitures $ 888,000      
Weighted average period for recognition of total unrecognized compensation expense (in years) 1 year 11 months      
Performance-based stock options        
Exercise Price Equal to Market Price [Abstract]        
Non-cash stock-based compensation expense     4,100  
Restricted stock        
Exercise Price Equal to Market Price [Abstract]        
Non-cash stock-based compensation expense $ 13,900 $ 15,300 $ 11,500  
Unrecognized stock-based compensation cost, net of estimated forfeitures $ 26,000      
Weighted average period for recognition of total unrecognized compensation expense (in years) 1 year 2 months      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Number of shares outstanding at beginning of period 541,700      
Number of shares granted 16,750      
Number of shares vested (11,590)      
Number of shares forfeited (40)      
Number of shares outstanding at end of period 546,820 541,700    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Weighted average grant date fair value at beginning of period $ 133.96      
Weighted average grant date fair value - granted 385.84      
Weighted average grant date fair value - vested 125.38      
Weighted average grant date fair value - forfeited 237.68      
Weighted average grant date fair value at end of period $ 141.85 $ 133.96    
Long-Term Incentive Plan 2000 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized for issuance       35,397,043
Long-Term Incentive Plan 2014 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized for issuance     16,485,333  
Number of shares available for future grants 6,408,989      
Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Number of shares exercised (1,697,000) (2,457,000) (3,468,000)  
Common Stock | Long-Term Incentive Plan 2014 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized for issuance     4,485,333